Cited by 57Escherichia coli research studiesBacterial Genetics and BiotechnologySalmonella and Campylobacter epidemiology

Shigella depends on SepA to destabilize the intestinal epithelial integrity via cofilin activation

Open access
Maldonado-Contreras, Ana, Birtley, James R., Boll, Erik, Zhao, Yun, Mumy, Karen L., Toscano, Juan, Ayehunie, Seyoum, Reinecker, Hans-Christian +2 more·2017·Gut Microbes

Abstract

Shigella is unique among enteric pathogens, as it invades colonic epithelia through the basolateral pole. Therefore, it has evolved the ability to breach the intestinal epithelial barrier to deploy an arsenal of effector proteins, which permits bacterial invasion and leads to a severe inflammatory response. However, the mechanisms used by Shigella to regulate epithelial barrier permeability remain unknown. To address this question, we used both an intestinal polarized model and a human ex-vivo model to further characterize the early events of host-bacteria interactions. Our results showed that secreted Serine Protease A (SepA), which belongs to the serine protease autotransporter of Enterobacteriaceae family, is responsible for critically disrupting the intestinal epithelial barrier. Such disruption facilitates bacterial transit to the basolateral pole of the epithelium, ultimately fostering the hallmarks of the disease pathology. SepA was found to cause a decrease in active LIM Kinase 1 (LIMK1) levels, a negative inhibitor of actin-remodeling proteins, namely cofilin. Correspondingly, we observed increased activation of cofilin, a major actin-polymerization factor known to control opening of tight junctions at the epithelial barrier. Furthermore, we resolved the crystal structure of SepA to elucidate its role on actin-dynamics and barrier disruption. The serine protease activity of SepA was found to be required for the regulatory effects on LIMK1 and cofilin, resulting in the disruption of the epithelial barrier during infection. Altogether, we demonstrate that SepA is indispensable for barrier disruption, ultimately facilitating Shigella transit to the basolateral pole where it effectively invades the epithelium.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/19490976.2017.1339006

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Bowen A. Chapter 3: Infectious Diseases Related to Travel. CDC; 2016 [updated Retrieved 22 June 2016.

Cited by

Sorted by citations

Authors
Maldonado-Contreras, A., Birtley, J. R., Boll, E., Zhao, Y., Mumy, K. L., Toscano, J., Ayehunie, S., Reinecker, H.-C., Stern, L. J., & McCormick, B. A.
Affiliations
  • Department of Microbiology and Physiological Systems, University of Massachusetts, Medical School
  • University of Massachusetts Chan Medical School (US)
  • Statens Serum Institut (DK)
  • Harvard University (US)
  • Wright-Patterson Air Force Base (US)
  • MatTek Corporation (United States) (US)
Corresponding author
McCormick, Beth A.
Venue
Gut Microbes
Published
2017-06-28
Volume
8
Issue
6
Pages
544-560
ISSN
  • 1949-0976 (ISSN-L)
  • 1949-0984
OpenAlex
W2624129866
Cited by
57
References
68
Citations by year
2026: 1 · 2025: 6 · 2024: 8 · 2023: 9 · 2022: 6 · 2021: 10 · 2020: 7 · 2019: 6 · 2018: 4
FWCI
3.58
Type
journal article
Language
en
Open access
Locations
  • Gut Microbes (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Energy (AC02‐06CH11357, 06CH11357, DE-AC02-)
  • Eli Lilly and Company
  • University of Massachusetts
  • Charles A. King Trust
  • National Institutes of Health (DE-AC02–06CH11357, DK33506, DK 043351)
  • Office of Science (AC02‐06CH11357, DE-AC02, 06CH11357, DE-AC02-06CH11357)
  • University of Massachusetts Medical School
  • National Institute of Allergy and Infectious Diseases (R37AI038996, R01AI081807, R01AI113333)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK056754, R01DK091247, R01DK068181, P30DK043351)
  • Argonne National Laboratory (DE- AC02-06-CH11357, DE-AC02, AC02–06CH11357, 06CH11357)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Escherichia coli research studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
Keywords
Shigella, SEPA, intestinal epithelial barrier, LIM kinase 1, actin cytoskeleton remodeling, tight junctions, serine protease activity, crystal structure, host-pathogen interaction, Shigella flexneri
MeSH terms
Bacterial Proteins, Humans, Intestinal Mucosa, Models, Biological, Mutation, Permeability, Phosphorylation, Shigella flexneri, Structure-Activity Relationship, Protein Structure, Secondary, Tight Junctions, Neutrophil Infiltration, Cell Line, Tumor, Actin Depolymerizing Factors, Host-Pathogen Interactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review